Prudential Financial
VIVO

Prudential Financial’s Meridian Bioscience Inc VIVO Stock Holding History

Prudential Financial’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-47,233
Closed -$1.57M – 2715
2022
Q4 		$1.57M Sell
47,233
-526
-1% -$16.9K ﹤0.01% 1452
2022
Q3 		$1.52M Sell
47,759
-11,470
-19% -$371K ﹤0.01% 1511
2022
Q2 		$1.8M Sell
59,229
-8,503
-13% -$230K ﹤0.01% 1445
2022
Q1 		$1.76M Sell
67,732
-13,331
-16% -$317K ﹤0.01% 1569
2021
Q4 		$1.65M Sell
81,063
-56,414
-41% -$1.08M ﹤0.01% 1625
2021
Q3 		$2.65M Sell
137,477
-370,545
-73% -$7.39M ﹤0.01% 1316
2021
Q2 		$11.3M Sell
508,022
-71,917
-12% -$1.53M 0.02% 721
2021
Q1 		$15.2M Sell
579,939
-260,326
-31% -$6.19M 0.02% 604
2020
Q4 		$15.7M Sell
840,265
-27,630
-3% -$516K 0.03% 547
2020
Q3 		$14.7M Buy
867,895
+153,074
+21% +$2.98M 0.03% 514
2020
Q2 		$16.6M Buy
714,821
+648,316
+975% +$9.4M 0.03% 499
2020
Q1 		$559K Sell
66,505
-1,319
-2% -$11.1K ﹤0.01% 1874
2019
Q4 		$663K Sell
67,824
-2,995
-4% -$28.1K ﹤0.01% 1987
2019
Q3 		$672K Sell
70,819
-13,405
-16% -$141K ﹤0.01% 1964
2019
Q2 		$1M Buy
84,224
+3,339
+4% +$40.2K ﹤0.01% 1874
2019
Q1 		$1.43M Sell
80,885
-531
-0.7% -$8.83K ﹤0.01% 1744
2018
Q4 		$1.41M Sell
81,416
-32,064
-28% -$547K ﹤0.01% 1693
2018
Q3 		$1.69M Sell
113,480
-132,050
-54% -$2.05M ﹤0.01% 1685
2018
Q2 		$3.9M Sell
245,530
-143,646
-37% -$2.14M 0.01% 1325
2018
Q1 		$5.53M Buy
389,176
+12,952
+3% +$192K 0.01% 1132
2017
Q4 		$5.27M Buy
376,224
+44,014
+13% +$644K 0.01% 1129
2017
Q3 		$4.75M Buy
332,210
+58,880
+22% +$841K 0.01% 1174
2017
Q2 		$4.3M Buy
273,330
+201,519
+281% +$2.9M 0.01% 1207
2017
Q1 		$991K Buy
71,811
+60
+0.1% +$839 ﹤0.01% 1856
2016
Q4 		$1.27M Sell
71,751
-2,870
-4% -$50.4K ﹤0.01% 1747
2016
Q3 		$1.44M Sell
74,621
-27,150
-27% -$531K ﹤0.01% 1671
2016
Q2 		$1.99M Buy
101,771
+1,180
+1% +$23.1K ﹤0.01% 1560
2016
Q1 		$2.07M Buy
100,591
+3,800
+4% +$74.9K ﹤0.01% 1537
2015
Q4 		$1.99M Buy
96,791
+1,400
+1% +$26.8K ﹤0.01% 1509
2015
Q3 		$1.63M Buy
95,391
+1,000
+1% +$18.3K ﹤0.01% 1551
2015
Q2 		$1.76M Sell
94,391
-3,900
-4% -$72.3K ﹤0.01% 1627
2015
Q1 		$1.88M Buy
98,291
+6,200
+7% +$115K ﹤0.01% 1619
2014
Q4 		$1.52M Sell
92,091
-600
-0.6% -$10.3K ﹤0.01% 1585
2014
Q3 		$1.64M Sell
92,691
-6,300
-6% -$124K ﹤0.01% 1520
2014
Q2 		$2.04M Buy
98,991
+4,300
+5% +$88.4K ﹤0.01% 1502
2014
Q1 		$2.06M Sell
94,691
-20,700
-18% -$474K ﹤0.01% 1456
2013
Q4 		$3.06M Sell
115,391
-12,600
-10% -$310K 0.01% 1220
2013
Q3 		$3.03M Buy
127,991
+417
+0.3% +$9.74K 0.01% 1182
2013
Q2 		$2.74M Buy
+127,574
New +$2.75M 0.01% 1194

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Prudential Financial's VIVO Position: Q1 2023 in Review

Prudential Financial sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 47,233 shares — an estimated $1.57M sold.

Prudential Financial first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $16.6M in Q2 2020. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Prudential Financial reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Prudential Financial sold 47,233 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.57M.
  • Prudential Financial first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
  • Prudential Financial's Meridian Bioscience Inc position peaked at $16.6M in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Prudential Financial's 13F filing for Q1 2023, filed 12 May 2023.